+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antivirals"

From
From
West Nile - Pipeline Insight, 2024 - Product Thumbnail Image

West Nile - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Lassa Fever - Pipeline Insight, 2024 - Product Thumbnail Image

Lassa Fever - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Herpes Simplex - Pipeline Insight, 2024 - Product Thumbnail Image

Herpes Simplex - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 75 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Influenza virus B infections - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza virus B infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Hepatitis C Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis C Virus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
Genital Warts - Pipeline Insight, 2024 - Product Thumbnail Image

Genital Warts - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
Marburg virus disease - Pipeline Insight, 2024 - Product Thumbnail Image

Marburg virus disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Chronic Pulmonary Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Pulmonary Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Influenza - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 280 Pages
  • Global
From
Norovirus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Norovirus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Smallpox - Pipeline Insight, 2024 - Product Thumbnail Image

Smallpox - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Dengue - Pipeline Insight, 2024 - Product Thumbnail Image

Dengue - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
H3N2 infection - Pipeline Insight, 2024 - Product Thumbnail Image

H3N2 infection - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 80 Pages
  • Global
From
From
Loading Indicator

The Antivirals market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat viral infections. Antivirals are used to treat a wide range of viral infections, including influenza, HIV, herpes, hepatitis, and other respiratory infections. Antivirals work by targeting the virus itself, preventing it from replicating and spreading throughout the body. They can also be used to reduce the severity of symptoms and shorten the duration of the illness. Antivirals are typically administered orally or intravenously, depending on the type of virus and the severity of the infection. In some cases, antivirals may be used in combination with other drugs to increase their effectiveness. Some of the major companies in the Antivirals market include Gilead Sciences, Merck & Co., Pfizer, GlaxoSmithKline, and Bristol-Myers Squibb. These companies produce a variety of antiviral drugs, including those used to treat influenza, HIV, herpes, and hepatitis. Show Less Read more